Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 37 out of 100. Vascular contributions

Topic: Brain proteins, microglia and lab models

Plain-language summary

Abstract Purpose White matter hyperintensities (WMHs) are commonly observed in aging and neurodegenerative diseases, but their impact on the α4β2 nicotinic acetylcholine receptor (α4β2-nAChR) system remains unclear. This study investigates the relationship between WMHs and gray matter nicotinic signaling, aiming to elucidate potential pathways contributing to neurodegeneration. Methods Multimodal imaging data using PET and MR imaging from 39 participants, including 19 healthy controls and 20 patients with Alzheimer’s disease dementia (AD), were analyzed. WMHs were identified on T1-weighted MPRAGE and T2-weighted TSE MR images using advanced segmentation algorithms. Probabilistic fiber tracking was applied to determine WMH-connected gray matter. PET-based total distribution volume ( V T ) values of the α4β2-nAChR tracer (-)-[ 18 F]Flubatine were compared between WMH-affected and unaffected gray matter regions. Results WMH volumes were significantly correlated with age, Fazekas and MMSE scores, but no differences in absolute or relative WMH volumes were observed between healthy controls and patients with AD. PET-based V T values in WMH-connected gray matter showed no significant difference from contralateral unaffected regions, regardless of disease status or WMH burden. However, intra-individual differences in V T values correlated with Fazekas scores, presumably driven by patients with AD. Pathway-based analyses revealed decreased V T values in the medial cholinergic pathway of patients with AD but no significant differences in lateral pathways. Conclusion This study shows that WMHs do not significantly alter gray matter nicotinic signaling in directly connected regions. However, the results suggest subtle associations between WMH severity and specific cholinergic pathways, particularly in AD.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Rullmann, M., Meyer, P., Schildan, A., Hoffmann, K., Sabri, O., & Tiepolt, S. (2025). Impact of white matter hyperintensities on α4β2 nicotinic acetylcholine receptor binding in the human brain. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-025-07383-z

Vancouver

Rullmann M, Meyer P, Schildan A, Hoffmann K, Sabri O, Tiepolt S. Impact of white matter hyperintensities on α4β2 nicotinic acetylcholine receptor binding in the human brain. European Journal of Nuclear Medicine and Molecular Imaging. 2025. doi:10.1007/s00259-025-07383-z. PMID: 40494919.

BibTeX

@article{rullmann2025-40494919,
  author  = {Rullmann, Michael and Meyer, Philipp and Schildan, Andreas and Hoffmann, Karl‐Titus and Sabri, Osama and Tiepolt, Solveig},
  title   = {{Impact of white matter hyperintensities on α4β2 nicotinic acetylcholine receptor binding in the human brain}},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year    = {2025},
  doi     = {10.1007/s00259-025-07383-z},
  pmid    = {40494919},
  url     = {https://doi.org/10.1007/s00259-025-07383-z}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

In 39 participants, white matter hyperintensity volumes correlated with age and cognitive scores, but nicotinic acetylcholine receptor binding in WMH-connected gray matter did not differ from unaffected regions. The study found no significant effect of WMH on this receptor system, though it did find decreased binding in the medial cholinergic pathway of Alzheimer's patients.

Study details

How this study scored 37/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 1 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 1 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 1 of 4; Institution's track record 1 of 3; Multicenter collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 37 of 100.37 of 100 points earned63 not earned

Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (European Journal of Nuclear Medicine and Molecular Imaging)
Journal's citation record 2 / 4 European Journal of Nuclear Medicine and Molecular Imaging: journal h-index 224 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 1 / 4 39 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.3 citations a year over 3 year(s) since 2025
Impact for its field and year 1 / 6 Cited 0.3× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 1 / 4 Last-listed author Solveig Tiepolt: h-index 19 (OpenAlex, whole career)
Institution's track record 1 / 3 Leipzig University: institution h-index 763 (OpenAlex)
Multicenter collaboration 1 / 3 OpenAlex lists 2 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40494919)
Free to read 2 / 2 Free to read
Total 37 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Vascular contributions from nearby years

Also tagged “tdp-43”

1,150 studies in the library carry the topic tag “tdp-43”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,150 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Vascular contributions

See all studies in Vascular contributions →